Wexford Capital’s Gilead Sciences GILD Stock Holding History

Wexford Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,851	Closed	-$502K	–	199
2022 Q4	$502K	Buy	+5,851	New	+$463K	0.1%	77
2021 Q1	–	Sell	-500	Closed	-$29K	–	259
2020 Q4	$29K	Hold	500	–	–	﹤0.01%	294
2020 Q3	$32K	Sell	500 -4,500	-90%	-$312K	0.01%	167
2020 Q2	$385K	Sell	5,000 -83,283	-94%	-$6.38M	0.1%	87
2020 Q1	$6.6M	Buy	+88,283	New	+$6.1M	2.44%	9
2017 Q3	–	Sell	-5,200	Closed	-$368K	–	166
2017 Q2	$368K	Buy	+5,200	New	+$346K	0.03%	125
2016 Q2	–	Sell	-54,026	Closed	-$4.96M	–	122
2016 Q1	$4.96M	Buy	54,026 +29,738	+122%	+$2.68M	0.97%	38
2015 Q4	$2.46M	Sell	24,288 -16,468	-40%	-$1.71M	0.58%	42
2015 Q3	$4M	Buy	+40,756	New	+$4.53M	0.77%	43
2015 Q1	–	Sell	-204,870	Closed	-$19.3M	–	69
2014 Q4	$19.3M	Buy	204,870 +195,870	+2,176%	+$20.3M	3.72%	4
2014 Q3	$958K	Sell	9,000 -211,819	-96%	-$20.7M	0.09%	83
2014 Q2	$18.3M	Buy	220,819 +205,819	+1,372%	+$16M	1.36%	6
2014 Q1	$1.06M	Sell	15,000 -10,000	-40%	-$784K	0.08%	109
2013 Q4	$1.88M	Sell	25,000 -221,621	-90%	-$15.4M	0.16%	81
2013 Q3	$15.5M	Sell	246,621 -44,160	-15%	-$2.64M	1.28%	7
2013 Q2	$14.9M	Buy	+290,781	New	+$15.2M	1.31%	8

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wexford Capital's GILD Position: Q1 2023 in Review

Wexford Capital sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 5,851 shares — an estimated $502K sold.

Wexford Capital first reported a position in GILD in Q2 2013 and held it in 16 quarters. The position peaked at $19.3M in Q4 2014. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Wexford Capital reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Wexford Capital sold 5,851 Gilead Sciences shares in Q1 2023, an estimated $502K.
Wexford Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 16 quarters.
Wexford Capital's Gilead Sciences position peaked at $19.3M in Q4 2014.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Wexford Capital's 13F filing for Q1 2023, filed 15 May 2023.